Manuscript Number : SHISRRJ193322

Protective Roles of Emblica Officinal as (AMLA) In Diabetes And Liver Of Rat.

Authors(1) :-Dr. Pramod Shanker

Emblica officinalis (Amla) are widely used in the Indian system of medicine and believed to increase defense against diseases. This article discuses and summarizes important medicinal values of Emblica officinalis (EO). In this communication, we reviewed the applications of EO in cancer, diabetis, liver treatment, heart disease, ulcer, anemia and various other diseases. Diabetes mellitus(DM), belongs to the class of metabolic diseases which the main symptom associated with this disease is the high sugar levels in blood for a long period. It can be categorized to the world’s major disease considering that affects high population in earth and presents two main types I and II. Diabetes complications include possible blindness, amputation of lower limb, renal failure and cardiac arrest or stroke.This article focuses on the effect of Emblica Officinalis (EO) especially in lowering the level of diabetes and protection of liver. This article also focuses the retrospective studies on the Amla at molecular level.

Authors and Affiliations

Dr. Pramod Shanker
TGT (Science), S.R.P.S. Govt. Sr. Sec. School, Gardanibagh, Patna, India

Emblica officinalis. Diseases. Medicinal value. Formulation

  1. Dnyaneshwar, , C. Preeti, J. Kalpana and P. Bhushan, 2006. Development and application of RAPD-SCAR marker for identification of Phyllanthus emblica LINN. Biol Pharm Bull., 29(11): 2313-6.
  2. Jain, K. and D.S. Khurdiya, 2004. Vitamin C enrichment of fruit juice based ready-to-serve beverages through blending of Indian gooseberry (Emblica officinalis Gaertn.) juice. Plant Foods Hum. Nutr., 59(2): 63-6.
  3. Zhang, Z., W.H. Zhao, Y.J. Guo, G.Z. Tu, S. Lin and L.G. Xin, 2003. Studies on chemical constituents in fruits of Tibetan medicine Phyllanthus emblica. Zhongguo Zhong Yao Za Zhi., 28(10): 940-3.
  4. Habib-ur-Rehman., A.   Yasin, M.A.  Choudhary,          14. Haque, R., B. Bin-Hafeez, I. Ahmad, S. Parvez,N.   Khaliq,   Atta-ur-Rahman.,   M.I.   Choudhary and S. Malik, 2007. Studies on the chemical constituents of  Phyllanthus  emblica.  Nat  Prod  Res., 20; 21(9): 775-81.
  5. El-Desouky, K., S.Y. Ryu and Y.K. Kim, 2008. A new cytotoxic acylated apigenin glucoside from Phyllanthus emblica L. Nat Prod Res., 22(1): 91-5.
  6. Deep, G., M. Dhiman, R. Rao and R.K. Kale, 2005. Chemopreventive potential of Triphala (a composite Indian drug) on benzo(a)pyrene induced forestomach tumorigenesis in murine tumor model system. J. Exp Clin Cancer Res., 24(4): 555-63.
  7. Veena, , P. Shanthi  and  P.  Sachdanandam,  2006. The biochemical alterations following administration of Kalpaamruthaa and Semecarpus anacardium in mammary carcinoma. Chem Biol Interact., 15; 161(1): 69-78.
  8. Sancheti, G., A. Jindal, R. Kumari and P.K. Goyal, 2005. Chemopreventive action of emblica officinalis on skin carcinogenesis in mice. Asian Pac J Cancer Prev., 6(2): 197-201.
  9. Sandhya, T., K.M. Lathika, B.N. Pandey and K.P. Mishra, 2006. Potential of traditional ayurvedic formulation, Triphala, as a novel anticancer drug. Cancer Lett., 231(2): 206-14.
  10. Kaur, S., H. Michael, S. Arora, P.L. Härkönen and S.Kumar, 2005. The in vitro cytotoxic and apoptotic activity of Triphala--an Indian herbal drug. J Ethnopharmacol., 10; 97(1): 15-20.
  11. Banu, M., K. Selvendiran, J.P. Singh and D. Sakthisekaran, 2004. Protective effect  of  Emblica officinalis ethanolic extract against 7, 12- dimethylbenz(a) anthracene (DMBA) induced genotoxicity in Swiss albino mice. Hum Exp Toxicol., 23(11): 527-31.
  12. Rajeshkumar, N.V., M.R. Pillai and R. Kuttan, 2003. Induction of apoptosis in mouse and human carcinoma cell lines by Emblica officinalis polyphenols and its effect on chemical carcinogenesis. J Exp Clin Cancer , 22(2): 201-12.
  13. Khan, M.T., I. Lampronti,  Martello,  N.   Bianchi, S. Jabbar,    M.S.    Choudhuri   B.K.    Datta    and R. Gambari, 2002. Identification of pyrogallol as an antiproliferative compound present in extracts from the medicinal plant Emblica officinalis: effects on in vitro cell growth of human tumor cell lines. Intl. J. Oncol., 21(1): 187-92.
  14. Pandey and S. Raisuddin, 2001. Protective effects of Emblica officinalis Gaertn. in
  15. cyclophosphamide- treated Hum Exp Toxicol., 20(12): 643-50.
  16. Zhang, J., T. Nagao, T. Tanaka, C.R. Yang,H. Okabe and I. Kouno, 2004. Antiproliferative activity of the main constituents from Phyllanthus emblica. Biol Pharm Bull., 27(2): 251-5.
  17. Suryanarayan, P., M. Saraswat, J.M. Petrash and B. Reddy, 2007. Emblica officinalis and its enriched tannoids delay streptozotocin-induced diabetic cataract in rats. Mol Vis., 24; 13: 1291-7.
  18. Suryanarayana, P., P.A. Kumar, M. Saraswat,J.M. Petrash and G.B. Reddy, 2004. Inhibition of aldose reductase by tannoid principles of Emblica officinalis: implications for the prevention of sugar cataract. Mol Vis., 12; 10:148-54.
  19. Bhattacharya, A., M. Kumar, S. Ghosal and S.K. Bhattacharya, 2000. Effect of bioactive tannoid principles of Emblica officinalis on iron-induced hepatic toxicity in rats. Phytomedicine., 7(2): 173-5.
  20. Pramyothin, , P. Samosorn, S. Poungshompoo andC. Chaichantipyuth, 2006. The protective effects of Phyllanthus emblica Linn. extract on ethanol induced rat hepatic injury. J Ethnopharmacol., 107(3): 361-4.
  21. Tasduq, S.A., P. Kaisar, D.K. Gupta, K. Kapahi,H.S. Maheshwari, S. Jyotsna, and R.K. Johri, 2005. Protective effect of a 50% hydroalcoholic fruit extract of Emblica officinalis against anti-tuberculosis drugs induced liver toxicity. Phytother Res., 19(3): 193-7.
  22. Sultana, S., S. Ahmad, Khanand T. Jahangir, 2005. Effect of Emblica officinalis (Gaertn) on CCl4 induced hepatic toxicity and DNA synthesis in Wistar rats. Indian J Exp Biol., 43(5): 430-6.
  23. Jose, K. and R. Kuttan, 2000. Hepatoprotective activity of Emblica officinalis and Chyavanaprash. J. Ethnopharmacol., 72(1-2): 135-40.
  24. Rajak, , S.K. Banerjee, S. Sood, A.K. Dinda,Y.K. Gupta, S.K. Guptaand S.K. Maulik, 2004. Emblica officinalis causes myocardial adaptation and protects against oxidative stress in ischemic-reperfusion injury in rats. Phytother Res., 18(1): 54-60.
  25. Bafna, P.A. and R. Balaraman, 2005. Anti-ulcer and anti-oxidant activity of pepticare, a herbomineral formulation. Phytomedicine., 12(4): 264-70.
  26. Sairam, ,  C.V.  Rao,  M.D.  Babu,  K.V.   Kumar, V.K. Agrawal and R.K. Goel, 2002. Antiulcerogenic effect of methanolic extract of Emblica officinalis: an experimental study. J Ethnopharmacol., 82(1): 1-9.

Publication Details

Published in : Volume 2 | Issue 1 | January-February 2019
Date of Publication : 2019-01-30
License:  This work is licensed under a Creative Commons Attribution 4.0 International License.
Page(s) : 252-259
Manuscript Number : SHISRRJ193322
Publisher : Shauryam Research Institute

ISSN : 2581-6306

Cite This Article :

Dr. Pramod Shanker , "Protective Roles of Emblica Officinal as (AMLA) In Diabetes And Liver Of Rat.", Shodhshauryam, International Scientific Refereed Research Journal (SHISRRJ), ISSN : 2581-6306, Volume 2, Issue 1, pp.252-259, January-February.2019
URL : https://shisrrj.com/SHISRRJ193322

Article Preview